1
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
728,585
$46.6m34.92%
34.92%
Unchanged Shares held: Q3 2022 727.8k, Q4 2022 727.8k, Q1 2023 728.6k, Q2 2023 728.6k
2
PROTHENA CORP PLC
SHS
PRTA
PRTA
156,111
$10.7m7.99%
7.99%
Added Shares held: Q3 2022 118.9k, Q4 2022 127.2k, Q1 2023 128.4k, Q2 2023 156.1k
+27.7k
+27,716
21.6%
3
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
84,240
$7.9m5.95%
5.95%
Unchanged Shares held: Q3 2022 85.2k, Q4 2022 84.2k, Q1 2023 84.2k, Q2 2023 84.2k
4
BIODESIX INC
COM
COM
5,039,633
$6.2m4.65%
4.65%
Unchanged Shares held: Q3 2022 2.4m, Q4 2022 5.0m, Q1 2023 5.0m, Q2 2023 5.0m
5
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
249,400
$6.0m4.48%
4.48%
Unchanged Shares held: Q3 2022 249.4k, Q4 2022 249.4k, Q1 2023 249.4k, Q2 2023 249.4k
6
QUIDEL CORP
COM
QDEL
QDEL
65,203
$5.4m4.05%
4.05%
Added Shares held: Q3 2022 61.3k, Q4 2022 61.3k, Q1 2023 61.3k, Q2 2023 65.2k
+3.9k
+3,897
6.4%
7
ELUTIA INC
CL A COM
ELUT
ELUT
1,655,184
$3.9m2.93%
2.93%
Unchanged Shares held: Q3 2022 1.4m, Q4 2022 1.5m, Q1 2023 1.7m, Q2 2023 1.7m
8
IMMUNOGEN INC
COM
IMGN
IMGN
190,000
$3.6m2.69%
2.69%
Added Shares held: Q3 2022 150.0k, Q4 2022 150.0k, Q1 2023 150.0k, Q2 2023 190.0k
+40.0k
+40,000
26.7%
9
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
15,000
$3.3m2.48%
2.48%
Unchanged Shares held: Q3 2022 15.0k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 15.0k
10
OVINTIV INC
COM
OVV
OVV
84,200
$3.2m2.40%
2.40%
Unchanged Shares held: Q3 2022 84.2k, Q4 2022 84.2k, Q1 2023 84.2k, Q2 2023 84.2k
11
HARROW INC
COM
HROW
HROW
150,000
$2.9m2.14%
2.14%
Reduced Shares held: Q3 2022 180.0k, Q4 2022 180.0k, Q1 2023 180.0k, Q2 2023 150.0k
-30.0k
-30,000
-16.7%
12
PHREESIA INC
COM
PHR
PHR
82,700
$2.6m1.92%
1.92%
Unchanged Shares held: Q3 2022 82.7k, Q4 2022 82.7k, Q1 2023 82.7k, Q2 2023 82.7k
13
MASIMO CORP
COM
MASI
MASI
15,280
$2.5m1.88%
1.88%
Unchanged Shares held: Q3 2022 15.3k, Q4 2022 15.3k, Q1 2023 15.3k, Q2 2023 15.3k
14
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
264,843
$1.9m1.40%
1.40%
Unchanged Shares held: Q3 2022 264.8k, Q4 2022 264.8k, Q1 2023 264.8k, Q2 2023 264.8k
15
INHIBRX INC
COM
INBX
INBX
70,448
$1.8m1.37%
1.37%
Unchanged Shares held: Q3 2022 70.4k, Q4 2022 70.4k, Q1 2023 70.4k, Q2 2023 70.4k
16
ACCELERATE DIAGNOSTICS INC
COM
COM
2,252,388
$1.8m1.37%
1.37%
Unchanged Shares held: Q3 2022 2.3m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.3m
17
ALKERMES PLC
SHS
ALKS
ALKS
50,000
$1.6m1.17%
1.17%
Unchanged Shares held: Q3 2022 50.0k, Q4 2022 50.0k, Q1 2023 50.0k, Q2 2023 50.0k
18
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
80,000
$1.4m1.08%
1.08%
Unchanged Shares held: Q3 2022 10.0k, Q4 2022 90.0k, Q1 2023 80.0k, Q2 2023 80.0k
19
EQUITRANS MIDSTREAM CORP
COM
ETRN
ETRN
133,050
$1.3m0.95%
0.95%
Unchanged Shares held: Q3 2022 133.1k, Q4 2022 133.1k, Q1 2023 133.1k, Q2 2023 133.1k
20
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
50,000
$1.1m0.83%
0.83%
Unchanged Shares held: Q3 2022 50.0k, Q4 2022 50.0k, Q1 2023 50.0k, Q2 2023 50.0k
21
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
12,000
$1.1m0.82%
0.82%
Unchanged Shares held: Q3 2022 12.0k, Q4 2022 12.0k, Q1 2023 12.0k, Q2 2023 12.0k
22
SOLENO THERAPEUTICS INC
COM
COM
245,127
$1.1m0.79%
0.79%
Unchanged Shares held: Q3 2022 245.1k, Q4 2022 245.1k, Q1 2023 245.1k, Q2 2023 245.1k
23
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
38,000
$1.0m0.79%
0.79%
Unchanged Shares held: Q3 2022 38.0k, Q4 2022 38.0k, Q1 2023 38.0k, Q2 2023 38.0k
24
DOCGO INC
COM
DCGO
DCGO
110,000
$1.0m0.77%
0.77%
Unchanged Shares held: Q3 2022 110.0k, Q4 2022 110.0k, Q1 2023 110.0k, Q2 2023 110.0k
25
IVERIC BIO INC
COM
OPHT
OPHT
25,000
$983.5k0.74%
0.74%
Unchanged Shares held: Q3 2022 25.0k, Q4 2022 25.0k, Q1 2023 25.0k, Q2 2023 25.0k
26
STOKE THERAPEUTICS INC
COM
STOK
STOK
85,000
$903.5k0.68%
0.68%
Added Shares held: Q3 2022 15.0k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 85.0k
+70.0k
+70,000
466.7%
27
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
26,400
$865.9k0.65%
0.65%
Unchanged Shares held: Q3 2022 45.0k, Q4 2022 22.0k, Q1 2023 26.4k, Q2 2023 26.4k
28
BLUEBIRD BIO INC
COM
COM
249,200
$819.9k0.61%
0.61%
Added Shares held: Q3 2022 98.0k, Q4 2022 98.0k, Q1 2023 199.2k, Q2 2023 249.2k
+50.0k
+50,000
25.1%
29
CYTOKINETICS INC
COM NEW
CYTK
CYTK
25,000
$815.5k0.61%
0.61%
Unchanged Shares held: Q3 2022 25.0k, Q4 2022 25.0k, Q1 2023 25.0k, Q2 2023 25.0k
30
PIONEER NAT RES CO
COM
PXD
PXD
3,800
$787.3k0.59%
0.59%
Unchanged Shares held: Q3 2022 3.8k, Q4 2022 3.8k, Q1 2023 3.8k, Q2 2023 3.8k
31
10X GENOMICS INC
CL A COM
TXG
TXG
12,000
$670.1k0.50%
0.50%
Added Shares held: Q3 2022 0, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 12.0k
+2.0k
+2,000
20.0%
32
SILK RD MED INC
COM
SILK
SILK
20,000
$649.8k0.49%
0.49%
Added Shares held: Q3 2022 10.0k, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 20.0k
+10.0k
+10,000
100.0%
33
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
40,000
$614.4k0.46%
0.46%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 30.0k, Q2 2023 40.0k
+10.0k
+10,000
33.3%
34
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
59,833
$605.5k0.45%
0.45%
Unchanged Shares held: Q3 2022 59.8k, Q4 2022 59.8k, Q1 2023 59.8k, Q2 2023 59.8k
35
CHINOOK THERAPEUTICS INC
COM
ADRO
ADRO
15,000
$576.3k0.43%
0.43%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 15.0k, Q2 2023 15.0k
36
KARYOPHARM THERAPEUTICS INC
COM
COM
291,332
$521.5k0.39%
0.39%
Unchanged Shares held: Q3 2022 269.3k, Q4 2022 291.3k, Q1 2023 291.3k, Q2 2023 291.3k
37
KINIKSA PHARMACEUTICALS LTD
COM CL A
COM CL A
30,000
$422.4k0.32%
0.32%
Unchanged Shares held: Q3 2022 30.0k, Q4 2022 30.0k, Q1 2023 30.0k, Q2 2023 30.0k
38
XENON PHARMACEUTICALS INC
COM
XENE
XENE
10,000
$385.0k0.29%
0.29%
Unchanged Shares held: Q3 2022 10.0k, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k
39
ARVINAS INC
COM
ARVN
ARVN
15,000
$372.3k0.28%
0.28%
Unchanged Shares held: Q3 2022 15.0k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 15.0k
40
AXOGEN INC
COM
AXGN
AXGN
40,000
$365.2k0.27%
0.27%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 40.0k
41
HALOZYME THERAPEUTICS INC
COM
HALO
HALO
10,000
$360.7k0.27%
0.27%
Unchanged Shares held: Q3 2022 0, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k
42
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
40,000
$360.0k0.27%
0.27%
Unchanged Shares held: Q3 2022 40.0k, Q4 2022 40.0k, Q1 2023 40.0k, Q2 2023 40.0k
43
PROGYNY INC
COM
PGNY
PGNY
9,000
$354.1k0.27%
0.27%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 9.0k, Q2 2023 9.0k
44
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
28,000
$351.7k0.26%
0.26%
Unchanged Shares held: Q3 2022 38.0k, Q4 2022 28.0k, Q1 2023 28.0k, Q2 2023 28.0k
45
XENCOR INC
COM
XNCR
XNCR
12,300
$307.1k0.23%
0.23%
Unchanged Shares held: Q3 2022 12.3k, Q4 2022 12.3k, Q1 2023 12.3k, Q2 2023 12.3k
46
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
2,500
$286.3k0.21%
0.21%
Unchanged Shares held: Q3 2022 2.5k, Q4 2022 2.5k, Q1 2023 2.5k, Q2 2023 2.5k
47
KEROS THERAPEUTICS INC
COM
KROS
KROS
7,000
$281.3k0.21%
0.21%
Unchanged Shares held: Q3 2022 0, Q4 2022 7.0k, Q1 2023 7.0k, Q2 2023 7.0k
48
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
25,114
$270.2k0.20%
0.20%
Unchanged Shares held: Q3 2022 25.1k, Q4 2022 25.1k, Q1 2023 25.1k, Q2 2023 25.1k
49
INFLARX NV
COM
IFRX
IFRX
50,000
$223.0k0.17%
0.17%
Reduced Shares held: Q3 2022 70.0k, Q4 2022 70.0k, Q1 2023 70.0k, Q2 2023 50.0k
-20.0k
-20,000
-28.6%
50
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
20,000
$140.8k0.11%
0.11%
Unchanged Shares held: Q3 2022 20.0k, Q4 2022 20.0k, Q1 2023 20.0k, Q2 2023 20.0k
51
GOSSAMER BIO INC
COM
GOSS
GOSS
99,088
$118.9k0.09%
0.09%
Unchanged Shares held: Q3 2022 159.1k, Q4 2022 99.1k, Q1 2023 99.1k, Q2 2023 99.1k
52
G1 THERAPEUTICS INC
COM
GTHX
GTHX
40,000
$99.6k0.07%
0.07%
Unchanged Shares held: Q3 2022 40.0k, Q4 2022 40.0k, Q1 2023 40.0k, Q2 2023 40.0k
53
YIELD10 BIOSCIENCE INC
COM
COM
18,750
$41.6k0.03%
0.03%
Unchanged Shares held: Q3 2022 18.8k, Q4 2022 18.8k, Q1 2023 18.8k, Q2 2023 18.8k
54
NEKTAR THERAPEUTICS
COM
COM
28,000
$16.1k0.01%
0.01%
Reduced Shares held: Q3 2022 128.0k, Q4 2022 118.0k, Q1 2023 118.0k, Q2 2023 28.0k
-90.0k
-90,000
-76.3%